Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Industry Panel: Considerations for Assessing Risk in Clinical Trials

Kevin Eggan, PhD. BioMarin, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.